| Lance Michon Craig, MD | |
|
270 Copperfield Blvd Ne Ste 101, Concord, NC 28025-2443 | |
| (704) 786-6521 | |
| (704) 782-9703 |
| Full Name | Lance Michon Craig |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 270 Copperfield Blvd Ne Ste 101, Concord, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295355220 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 261851 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lance Michon Craig, MD 270 Copperfield Blvd Ne Ste 202, Concord, NC 28025-2441 Ph: (704) 721-2020 | Lance Michon Craig, MD 270 Copperfield Blvd Ne Ste 101, Concord, NC 28025-2443 Ph: (704) 786-6521 |
News Archive
Over-the-counter facial moisturizers are a widely-used and commonly recommended skin care product, but a new study from dermatologists at Massachusetts General Hospital finds that, when it comes to price, men's and women's products are not considered equal.
The Center for Strategic & International Studies (CSIS) "wanted to learn more about how women leaders in Africa are bringing new attention to women's health and empowerment in their own countries, and to bring those voices into the discussion about U.S. policy priorities for women's global health," so a small CSIS team traveled to Malawi and Zambia in December 2012, Janet Fleischman and Julia Nagel of CSIS write in the group's Smart Global Health blog.
XenoPort, Inc. announced today that the first subjects have been dosed in a Phase 1, randomized, double-blind, two-period crossover, food effect comparison study of XP23829 in healthy adults. The trial is designed to assess the pharmacokinetics, safety and tolerability of a single dose of XP23829 administered in both fasted and fed conditions.
A genetic modification in the 'coat' of a brain infection-causing virus may allow it to escape antibodies, according to Penn State College of Medicine researchers.
Bristol-Myers Squibb Company and Oncolys BioPharma Inc., a privately held biotechnology company based in Japan, announced today that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire exclusive worldwide rights to manufacture, develop and commercialize festinavir, a once-a-day, orally available nucleoside reverse transcriptase inhibitor (NRTI) in Phase II development for HIV.
› Verified 6 days ago
Bridget Chinelo Nduka, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 7752 Gateway Ln Nw Ste 100, Concord, NC 28027 Phone: 704-316-4950 Fax: 704-316-4951 | |
Brent Halsch, Family Medicine Medicare: Medicare Enrolled Practice Location: 6150 Bayfield Pkwy, Concord, NC 28027 Phone: 704-262-6081 | |
Rebecca Delaney, Family Medicine Medicare: Medicare Enrolled Practice Location: 5641 Poplar Tent Rd, Suite 101, Concord, NC 28027 Phone: 704-782-1955 | |
Paul Brezicki, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1090 Ne Gateway Ct Ne, Ste 202, Concord, NC 28025 Phone: 704-403-9050 | |
David C. Tignor, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5641 Poplar Tent Rd, Ste 101, Concord, NC 28027 Phone: 704-782-1955 | |
Mark Reiff, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 431 Copperfield Blvd Ne, Ste 100, Concord, NC 28025 Phone: 704-403-9300 | |
Lori Mcclellan, FNP Family Medicine Medicare: Medicare Enrolled Practice Location: 101 Cabarrus Ave E, Concord, NC 28025 Phone: 888-849-7379 |